The Drugs and Devices Have Been on the Market for Years. But FDA-Ordered Studies Still Aren’t Done.

To get drugs and devices out faster, the FDA lets companies conduct studies of safety or efficacy after the products are approved. In many cases, such “postmarket” studies are behind schedule or overdue, records show.